Literature DB >> 31364258

Bioinspired Core-Shell Nanoparticles for Hydrophobic Drug Delivery.

Guangze Yang1, Yun Liu1, Haofei Wang1, Russell Wilson1, Yue Hui1, Lei Yu1, David Wibowo1, Cheng Zhang1,2, Andrew K Whittaker1,2, Anton P J Middelberg1,3, Chun-Xia Zhao1.   

Abstract

A large range of nanoparticles have been developed to encapsulate hydrophobic drugs. However, drug loading is usually less than 10 % or even 1 %. Now, core-shell nanoparticles are fabricated having exceptionally high drug loading up to 65 % (drug weight/the total weight of drug-loaded nanoparticles) and high encapsulation efficiencies (>99 %) based on modular biomolecule templating. Bifunctional amphiphilic peptides are designed to not only stabilize hydrophobic drug nanoparticles but also induce biosilicification at the nanodrug particle surface thus forming drug-core silica-shell nanocomposites. This platform technology is highly versatile for encapsulating various hydrophobic cargos. Furthermore, the high drug loading nanoparticles lead to better in vitro cytotoxic effects and in vivo suppression of tumor growth, highlighting the significance of using high drug-loading nanoparticles.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biomimetic synthesis; cancer; drug delivery; nanoparticles; peptides

Year:  2019        PMID: 31364258     DOI: 10.1002/anie.201908357

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  13 in total

1.  Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.

Authors:  Radhika Narayanaswamy; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2021-03-02       Impact factor: 4.200

2.  Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer.

Authors:  Qin Gxin Mu; Guanyou Lin; Mike Jeon; Hui Wang; Fei-Chien Chang; Richard A Revia; John Yu; Miqin Zhang
Journal:  Mater Today (Kidlington)       Date:  2021-09-07       Impact factor: 31.041

3.  Efficient Delivery of Curcumin by Alginate Oligosaccharide Coated Aminated Mesoporous Silica Nanoparticles and In Vitro Anticancer Activity against Colon Cancer Cells.

Authors:  Chennan Liu; Fangyuan Jiang; Zifeng Xing; Lihong Fan; Yuan Li; Shaoning Wang; Junhong Ling; Xiao-Kun Ouyang
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

Review 4.  Unique Properties of Surface-Functionalized Nanoparticles for Bio-Application: Functionalization Mechanisms and Importance in Application.

Authors:  Faheem Ahmad; Mounir M Salem-Bekhit; Faryad Khan; Sultan Alshehri; Amir Khan; Mohammed M Ghoneim; Hui-Fen Wu; Ehab I Taha; Ibrahim Elbagory
Journal:  Nanomaterials (Basel)       Date:  2022-04-13       Impact factor: 5.719

Review 5.  Nanotherapeutics and the Brain.

Authors:  Andrea Joseph; Elizabeth Nance
Journal:  Annu Rev Chem Biomol Eng       Date:  2022-03-23       Impact factor: 9.700

6.  Plasmon-Enhanced Controlled Drug Release from Ag-PMA Capsules.

Authors:  Giulia Neri; Carmelo Corsaro; Enza Fazio
Journal:  Molecules       Date:  2020-05-11       Impact factor: 4.411

7.  A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer's Disease Therapy.

Authors:  Ying Kuang; Jingwen Zhang; Mogao Xiong; Weijia Zeng; Xiaofeng Lin; Xiaoqing Yi; Yan Luo; Min Yang; Feng Li; Qitong Huang
Journal:  Front Bioeng Biotechnol       Date:  2020-12-03

Review 8.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

9.  Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment.

Authors:  Naveed Ullah Khan; Jiang Ni; Xiufeng Ju; Tongtong Miao; Haiyan Chen; Liang Han
Journal:  Acta Pharm Sin B       Date:  2020-10-21       Impact factor: 11.413

Review 10.  Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation.

Authors:  Guorong Hu; Mengfei Guo; Juanjuan Xu; Feng Wu; Jinshuo Fan; Qi Huang; Guanghai Yang; Zhilei Lv; Xuan Wang; Yang Jin
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.